Estimating the transfusion transmission risk of Q fever

The Q fever outbreaks in the Netherlands in 2007 to 2009 initiated discussion on the necessity of measures to prevent transmission through blood products. Risk assessments help transfusion regulators decide when and where measures are required. This study assesses the transfusion transmission (TT) risk of Q fever using the European Up‐Front Risk Assessment Tool (EUFRAT) model.

[1]  E. Slot,et al.  Screening of blood donors for chronic Coxiella burnetii infection after large Q fever outbreaks , 2014, Transfusion.

[2]  Welling Oei,et al.  Modeling the transmission risk of emerging infectious diseases through blood transfusion , 2013, Transfusion.

[3]  E. Slot,et al.  Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands , 2013, Transfusion.

[4]  C. A. Groot,et al.  Identification of Risk Factors for Chronic Q Fever, the Netherlands , 2012, Emerging infectious diseases.

[5]  B. Schimmer,et al.  The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. , 2012, FEMS immunology and medical microbiology.

[6]  W. van der Hoek,et al.  Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  E. V. van Hannen,et al.  Coxiella burnetii infection among blood donors during the 2009 Q‐fever outbreak in the Netherlands , 2012, Transfusion.

[8]  Bba,et al.  Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control of the National Institute for Public Health and Environment (RIVM) , 2011 .

[9]  N. Renders,et al.  Follow-up of 686 patients with acute Q fever and detection of chronic infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Vercoulen,et al.  The health status of Q-fever patients after long-term follow-up , 2011, BMC infectious diseases.

[11]  B. Custer,et al.  Modeling the risk of an emerging pathogen entering the Canadian blood supply , 2010, Transfusion.

[12]  Y. V. van Duynhoven,et al.  Q fever in the Netherlands: an update on the epidemiology and control measures. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  B. Schimmer,et al.  The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak , 2010, BMC infectious diseases.

[14]  E. V. van Hannen,et al.  Real-Time PCR with Serum Samples Is Indispensable for Early Diagnosis of Acute Q Fever , 2009, Clinical and Vaccine Immunology.

[15]  V. Sambri,et al.  The Chikungunya epidemic in Italy and its repercussion on the blood system. , 2008, Blood transfusion = Trasfusione del sangue.

[16]  D. Raoult,et al.  Comparison of PCR and Serology Assays for Early Diagnosis of Acute Q Fever , 2003, Journal of Clinical Microbiology.

[17]  B. Biggerstaff,et al.  Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002 , 2003, Transfusion.

[18]  D. Raoult,et al.  Q Fever 1985‐1998: Clinical and Epidemiologic Features of 1,383 Infections , 2000, Medicine.

[19]  D. Huitema.  Election manifestoes as the meeting point for experts and politicians in the Netherlands: the case of the National Institute for Public Health and the Environment (RIVM) , 2007 .

[20]  F Nistal de Paz,et al.  [Q fever]. , 1994, Medicina clinica.